Icon times
Sun Pharmas Performance Review (5 Reasons for subdued performance)

Sun Pharmas Performance Review (5 Reasons for subdued performance)

Published on 12 December 2020 Views 189 Comments 2

Nifty Pharma index has doubled from its lows in March 2020. But, the story is different for India’s largest pharma company - Sun Pharmaceutical Industries. Sun Pharma has underperformed its peers such as Dr. Reddy’s Laboratories, Cipla, Aurobindo Pharma as well as the Nifty Pharma index. Why the company’s performance is subdued vs its peers?
 
Attachments
File Name
private article suscription area icon

You like to know more. We like that!

Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs 7499/Year.

Please login to view this free article.

This blog is available only for logged in users, please register and get access to view this article.

LATEST UPDATE

premium Premium
free Free
Read More

REPORTS


Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya